FDA panel backs Merck anti-infective Zinplava

FDA's Antimicrobial Drugs Advisory Committee voted 10-5, with one abstention, that Merck & Co. Inc. (NYSE:MRK)

Read the full 167 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE